Skip to main content
The BMJ logoLink to The BMJ
letter
. 1990 Apr 21;300(6731):1074–1075. doi: 10.1136/bmj.300.6731.1074-b

Thyroxine replacement treatment and osteoporosis.

PMCID: PMC1662763  PMID: 2386584

Full text

PDF
1074

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alaghband-Zadeh J., Carter G. D., Daly J. R., Fowler P. B., Greenwood T. W. Association between exaggerated responsiveness to thyrotrophin-releasing hormone and hypercholesterolaemia. Lancet. 1977 Nov 12;2(8046):998–1000. doi: 10.1016/s0140-6736(77)92894-x. [DOI] [PubMed] [Google Scholar]
  2. Dean J. W., Fowler P. B. Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. Br Med J (Clin Res Ed) 1985 May 25;290(6481):1555–1561. doi: 10.1136/bmj.290.6481.1555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fowler P. B., Swale J., Andrews H. Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet. 1970 Sep 5;2(7671):488–491. doi: 10.1016/s0140-6736(70)90111-x. [DOI] [PubMed] [Google Scholar]
  4. Fowler P. S., Swale J. Premyxoedema and coronary-artery disease. Lancet. 1967 May 20;1(7499):1077–1079. doi: 10.1016/s0140-6736(67)92650-5. [DOI] [PubMed] [Google Scholar]
  5. Franklyn J. A., Sheppard M. C. Thyroxine replacement treatment and osteoporosis. BMJ. 1990 Mar 17;300(6726):693–694. doi: 10.1136/bmj.300.6726.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Powell J., Zadeh J. A., Carter G., Greenhalgh R. M., Fowler P. B. Raised serum thyrotrophin in women with peripheral arterial disease. Br J Surg. 1987 Dec;74(12):1139–1141. doi: 10.1002/bjs.1800741220. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES